Market Size in 2022 | Market Forecast in 2030 | CAGR (in %) | Base Year |
---|---|---|---|
USD 3,698.74 Million | USD 5,473.06 Million | 5.02% | 2022 |
The global antibiotic susceptibility testing market size was worth around USD 3,698.74 million in 2022 and is predicted to grow to around USD 5,473.06 million by 2030 with a compound annual growth rate (CAGR) of roughly 5.02% between 2023 and 2030.
Antibiotic susceptibility testing is a laboratory performed process that is carried out under the guidance of medical professionals like technologists in order to identify the antibiotic regimen and check whether it is effective for the individual patient or not. It has also helped in the judgment of therapy service supplied by clinics, national programs, and hospitals all across the world to prevent infectious diseases. Such tests determine the susceptibility of fungi or bacteria and their sensitivity towards antibodies. This screening system facilitates the real-time detection for antibiotic susceptibility testing and associated bacterial growth with imaging material in order to manage and support the automatically generated graphs.
The growing prevalence of infections owing to the presence of a large number of pathogens and bacteria is the major factor driving the growth of the global antibiotic susceptibility testing market. Also, the growing epidemic situation all across the globe and a large number of diseases transmitted from one person to another are factors significantly propelling the growth of the global market. The growing stringent rules and regulations from government authorities on new instruments and product approval are likely to positively shape the trajectory of the global market during the forecast period.
Moreover, the genomic identification helps in the novel testing method that will assist in detecting the pathogenic susceptibility accurately in a very short period of time. The emergence of many new market players with innovative testing methods and novel technology that facilitate effective results in less time further bolsters the growth of the global antibiotic susceptibility testing market. The increasing concentration of healthcare authorities on examining antibiotic susceptibility in order to ensure the safety and efficacy of AST methods is further augmenting the growth of the global antibiotic susceptibility testing market.
The growing research and development activities in order to launch better testing methods in the market is further escalating the growth of the global market. In addition, the growing expenditure on healthcare infrastructure is significantly boosting the growth of the global market. The government is increasing healthcare expenditure for the adoption of more sophisticated and efficient antibiotic susceptibility testing systems and techniques. The high adoption rate of online distribution channels is further accelerating the growth of sales in the global antibiotic susceptibility testing market. Such distribution channels help vendors to cut down the distribution and operational costs and hence boost the profit margin. Also, the online platform assists vendors to provide information regarding their devices in their portfolio in order to gain local as well as global market access.
Report Attributes | Report Details |
---|---|
Report Name | Antibiotic Susceptibility Testing Market Research Report |
Market Size in 2022 | USD 3,698.74 Million |
Market Forecast in 2030 | USD 5,473.06 Million |
Growth Rate | CAGR of 5.02% |
Number of Pages | 215 |
Key Companies Covered | Merck KgaA, bioMérieux SA, Liofilchem Srl, Alifax, Accelerate Diagnostics, Creative Diagnostics, Bio-Rad Laboratories, Thermo Fisher Scientific, Danaher, and BD. |
Segments Covered | By Product Type, By Application, By End User and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2023 - 2030 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The global antibiotic susceptibility testing market can be segmented into end-user, application, product type, and region.
By end-user, the market can be segmented into diagnostic laboratories, hospitals, and research laboratories. The hospital segment accounts for the largest share in the global antibiotic susceptibility testing market as a large number of tests are performed in hospitals.
By application, the market can be segmented into endocarditis, meningitis & encephalitis, gastrointestinal infections, respiratory infection, sepsis, and others.
By product type, the market can be segmented into kits & reagents, software & services, and instruments.
North America accounts for the largest share in the global antibiotic susceptibility testing market due to the growing technological advancements in the region. Moreover, the growing investments from government authorities as well as prominent market players to innovate advanced methods to test the susceptibility of antibiotics further boost the growth of the regional market.
Asia Pacific is anticipated to witness huge growth during the forecast period due to the growing initiatives from the government authorities to strengthen the healthcare infrastructure in the region.
The global antibiotic susceptibility testing market is led by players like:
By Product Type
By End-User
By Application
Global Antibiotic Susceptibility Testing Market: Regional Segment Analysis
What Reports Provides
FrequentlyAsked Questions
Antibiotic susceptibility testing (AST) is a laboratory methodology employed to ascertain the antimicrobial efficacy of particular strains of bacteria or fungi. The objective of this diagnostic procedure is to ascertain the antibiotic therapy that is both optimal and efficacious in treating a specific infection. It assists medical professionals in determining which antibiotic the pathogenic microorganism is resistant to.
Antibiotic-resistant bacterium proliferation around the world is a significant factor propelling the expansion of the AST market. The increasing prevalence of antibiotic resistance necessitates the implementation of precise and expeditious susceptibility testing in order to assist medical professionals in the prescription of efficacious antibiotics. Continuous developments in laboratory techniques and technologies for AST contribute to market expansion. Enhancements in testing method sensitivity, automation, and miniaturization contribute to the enhanced efficacy and precision of susceptibility testing.
The global antibiotic susceptibility testing market size was worth around USD 3,698.74 million in 2022 and is predicted to grow to around USD 5,473.06 million by 2030.
The global antibiotic susceptibility testing market with a compound annual growth rate (CAGR) of roughly 5.02% between 2023 and 2030.
North America accounts for the largest share in the global antibiotic susceptibility testing market due to the growing technological advancements in the region. Moreover, the growing investments from government authorities as well as prominent market players to innovate advanced methods to test the susceptibility of antibiotics further boost the growth of the regional market.
Some of the significant players in the global antibiotic susceptibility testing market are Merck KgaA, bioMérieux SA, Liofilchem Srl, Alifax, Accelerate Diagnostics, Creative Diagnostics, Bio-Rad Laboratories, Thermo Fisher Scientific, Danaher, and BD.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed